Printer Friendly

General Richard Neal, Former U.S. Marine Corps Asst Commandant, Named as Director of Humanetics Corporation; Neal Brings Private Sector Experience with Defense-Related Companies to Board Position.

MINNEAPOLIS -- Richard I. Neal, the highly decorated four-star General and field commander whose most recent post was as Assistant Commandant of the United States Marine Corps, was elected to the Humanetics Corporation Board of Directors, effective January 1, 2006, the Company announced today.

Neal, who retired from the U.S. Marine Corps in 1998, has extensive private sector experience in the area of intellectual property and in working with defense-related companies. This experience, combined with his background in strategic planning and organizational leadership, made him an attractive board candidate for the Company, according to Ronald Zenk, the Company's President and CEO. Humanetics currently is working with various Department of Defense-affiliated organizations to develop oral countermeasures to ionizing radiation resulting from a nuclear attack or dirty bomb.

"General Neal's knowledge of the U.S. military--as well as his experience in helping companies navigate the complexities of U.S. government contracts--will be of great assistance to Humanetics as we continue our work with the Department of Defense. We are delighted that General Neal has agreed to join our Board of Directors," Zenk said.

Neal said that he is pleased to be associated with Humanetics Corporation. "This is an exciting and growing company that is creating a new paradigm in drug development," he said. "I'm looking forward to contributing to this effort as a board member."

Neal is President of Audio MPEG, a patent licensing company located in Alexandria, Virginia and resides in Washington, D.C.

Humanetics Developing Radiation Countermeasures

Late last year, Humanetics was granted an exclusive worldwide license to further test, develop and commercialize an oral agent, BIO300, to strengthen and protect the immune system against exposure to ionizing radiation.

BIO300 was discovered by the National Institutes of Health and the Armed Forces Radiobiology Research Institute (AFRRI). Humanetics will collaborate on development of BIO300 with AFRRI, which is considered the country's premier center for radiation injury countermeasure research.

During 2005, Humanetics and AFRRI pursued a number of oral countermeasures, many of which have been shown effective in increasing survival in mice receiving otherwise lethal doses of radiation. Based on animal screening models, BIO300 emerged as the leading candidate for commercialization.

From Battlefield to Board Room

General Neal's four-star military career spanned nearly three decades, beginning in Vietnam in 1966 and continuing through Operation Desert Shield/Desert Storm in 1991. During that time, Neal served as Deputy of Operations at U.S. Central Command. From 1996-1998, Neal was the Assistant Commandant of the Marine Corps, leading senior staff coordination, development and implementation of policy and financial plans for a 200,000 person organization and a $10.8 billion budget.

Since his retirement in 1998, Neal has served as a member of several Customer Advisory Boards and is on the Board of Directors for several defense-related companies.

Humanetics is a privately-held specialty pharmaceutical company headquartered in Minneapolis, Minnesota. The Company is focused on the rapid discovery, development and commercialization of orally-administered bioactive compounds for the prevention and treatment of diseases in categories with urgent and unmet needs. The Company has several proprietary compounds in preclinical and/or clinical stages of development in the areas of bioterrorism, Alzheimer's disease and obesity. For more information, visit:

This Press Release contains discussion of certain expectations regarding Humanetics' future performance. These forward-looking statements are based on the Company's current views and assumptions. Actual results could differ materially from these current expectations and projections, and from historical performance.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion




Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 12, 2006
Previous Article:How a Weak Housing Market, and a Slow Consumer Credit Market Will Affect the UK Non-Standard and Sub-Prime Lenders.
Next Article:Historic Preservation Conference Features National Speakers, Celebrations and Trade Show.

Related Articles
Industry. (Brass Tracks).
Brass tracks.
Marine Corps international education and training.

Terms of use | Copyright © 2015 Farlex, Inc. | Feedback | For webmasters